Table 1 Baseline characteristics and stimulation cycle parameters of patients
PPOS group (n = 299) | GnRH antagonist group (n = 299) | P value | |
|---|---|---|---|
Female age (year) | 36.73 ± 5.19 | 36.70 ± 5.25 | 0.931 |
Male age (year) | 39.41 ± 5.96 | 38.81 ± 6.28 | 0.227 |
BMI (kg/m2) | 22.44 ± 2.80 | 22.32 ± 2.99 | 0.631 |
AMH (ng/ml) | 3.86 ± 3.77 | 4.10 ± 3.78 | 0.444 |
bFSH (IU/L) | 7.33 ± 2.71 | 7.03 ± 2.13 | 0.156 |
Indication for PGT-A | 0.277 | ||
Advanced maternal age | 90 | 104 | |
Recurrent miscarriage | 126 | 129 | |
Repeated implantation failure | 19 | 11 | |
Mixed | 64 | 55 | |
Initial gonadotrophin dose (IU) | 248.08 ± 63.27 | 236.20 ± 69.66 | 0.030* |
Total gonadotrophin dose (IU) | 2356.33 ± 715.93 | 2360 ± 851.41 | 0.952 |